Page last updated: 2024-10-27

fluconazole and Genetic Non-Disjunction

fluconazole has been researched along with Genetic Non-Disjunction in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perepnikhatka, V1
Fischer, FJ1
Niimi, M1
Baker, RA1
Cannon, RD1
Wang, YK1
Sherman, F1
Rustchenko, E1

Other Studies

1 other study available for fluconazole and Genetic Non-Disjunction

ArticleYear
Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans.
    Journal of bacteriology, 1999, Volume: 181, Issue:13

    Topics: Aneuploidy; Antifungal Agents; Arabinose; Candida albicans; Chromosomes, Fungal; Drug Resistance, Mi

1999